Pharmaron Beijing Co Ltd (300759) — Cash Flow Reinvestment Rate
Pharmaron Beijing Co Ltd (300759) has a Cash Flow Reinvestment Rate of 0.72x as of September 2025, reinvesting CN¥746.35 Million (capex CN¥746.35 Million ) from operating cash flow of CN¥1.04 Billion. See Pharmaron Beijing Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharmaron Beijing Co Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for Pharmaron Beijing Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see Pharmaron Beijing Co Ltd (300759) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year capital reinvestment analysis for Pharmaron Beijing Co Ltd. See 300759 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.81x | CN¥2.09 Billion | CN¥2.58 Billion | CN¥2.04 Billion | ▼ -56.3% |
| 2023 | 1.86x | CN¥5.12 Billion | CN¥2.75 Billion | CN¥2.87 Billion | ▼ -22.8% |
| 2022 | 2.41x | CN¥5.16 Billion | CN¥2.14 Billion | CN¥2.95 Billion | ▲ +20.5% |
| 2021 | 2.00x | CN¥4.11 Billion | CN¥2.06 Billion | CN¥2.09 Billion | ▲ +27.4% |
| 2020 | 1.57x | CN¥2.59 Billion | CN¥1.65 Billion | CN¥1.32 Billion | ▲ +53.5% |
| 2019 | 1.02x | CN¥959.24 Million | CN¥938.59 Million | CN¥754.61 Million | ▲ +2.2% |
| 2018 | 1.00x | CN¥736.98 Million | CN¥737.26 Million | CN¥640.99 Million | ▼ -46.4% |
| 2017 | 1.87x | CN¥1.03 Billion | CN¥552.22 Million | CN¥934.67 Million | ▼ -79.9% |
| 2016 | 9.31x | CN¥2.19 Billion | CN¥235.77 Million | CN¥1.06 Billion | ▲ +681.7% |
| 2015 | 1.19x | CN¥258.32 Million | CN¥216.94 Million | CN¥258.32 Million | ▼ -82.4% |
| 2014 | 6.75x | CN¥81.94 Million | CN¥12.13 Million | CN¥81.94 Million | — |